Methotrexate - Inadequate Response Device Sub-Study

NCT01173120 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

62

Enrollment

INDUSTRY

Sponsor class

Conditions

Rheumatoid Arthritis (RA)

Interventions

DEVICE: Abatacept combination product (ACP)

Sponsor

Bristol-Myers Squibb